Gupta, A., D, V., Nawaz, A., & Hari, V. (2025). Therapy related myelodysplastic syndrome: A hematologic sequela of low dose methotrexate in rheumatoid arthritis. Oxford Medical Case Reports, 2025(11), 1. https://doi.org/10.1093/omcr/omaf253
Chicago Style (17th ed.) CitationGupta, Ayushi, Venugopala D, Alam Nawaz, and Vivek Hari. "Therapy Related Myelodysplastic Syndrome: A Hematologic Sequela of Low Dose Methotrexate in Rheumatoid Arthritis." Oxford Medical Case Reports 2025, no. 11 (2025): 1. https://doi.org/10.1093/omcr/omaf253.
MLA (9th ed.) CitationGupta, Ayushi, et al. "Therapy Related Myelodysplastic Syndrome: A Hematologic Sequela of Low Dose Methotrexate in Rheumatoid Arthritis." Oxford Medical Case Reports, vol. 2025, no. 11, 2025, p. 1, https://doi.org/10.1093/omcr/omaf253.